VBI Vaccines

VBI Vaccines

MA - Cambridge
Biotechnology

Focus: Vaccine Development

VBI Vaccines is a life sciences company focused on Vaccine Development.

Infectious DiseasesVaccines
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0

Pipeline & Clinical Trials

Clinical Trials (1)
NCT06097312PREHEVBRIO Pregnancy Outcomes Registry
N/A
Phase 1
Clinical Trials (1)
NCT02826798Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
Phase 1
VBI-2902a
Covid19
Phase 1
Clinical Trials (1)
NCT04773665Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a
Phase 1
VBI-2901a
COVID-19
Phase 1
Clinical Trials (1)
NCT05548439Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a
Phase 1
VBI-2901e
COVID-19
Phase 1
Clinical Trials (1)
NCT05614245Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant
Phase 1
Phase 1/2
Clinical Trials (1)
NCT03382977Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
Phase 1/2
Phase 2
Clinical Trials (1)
NCT04749368Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection
Phase 2
Hepatitis B Vaccination
Hepatitis B Vaccines
Phase 3
Clinical Trials (1)
NCT03393754Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults
Phase 3
Sci-B-Vac-Lot B
Hepatitis B
Phase 3
Clinical Trials (1)
NCT04531098A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults
Phase 3
Hepatitis B Vaccination
Hepatitis B Vaccines
Phase 3
Clinical Trials (1)
NCT03408730Lot-to-lot Consistency of Sci-B-Vac™ in Adults
Phase 3
Sci-B-Vac®
Hepatitis B
Phase 3
Clinical Trials (1)
NCT04209400Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®
Phase 3
Sci-B-Vac™
Hepatitis B
Phase 4
Clinical Trials (1)
NCT04179786A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2008
Portfolio: 12 clinical trials

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles